Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.
Paroxysmal nocturnal hemoglobinuria (PNH) and the stable phase of chronic myelogenous leukemia (CML) are the two hematological conditions known to be associated with low levels of leukocyte alkaline phosphatase (LAP) activity in peripheral blood polymorphonuclear cells (PMN). LAP mRNA levels were determined in PMN from PNH and CML patients by RNA blotting analysis. In CML, LAP mRNA is undetectable, suggesting either decreased transcription or rapid degradation of the message. Contrarily, in PNH normal or high levels of LAP mRNA are present. This latter finding supports the concept of a deficit in the anchorage of the protein to the plasma membrane through the glycolipid pathway, even though other post-transcriptional mechanisms could be involved.
Rambaldi
A
A
Istituto di Ricerche, Farmacologiche Mario Negri, Milano, Italy.
Terao
M
M
Bettoni
S
S
Bassan
R
R
Battista
R
R
Barbui
T
T
Garattini
E
E
D000469:Alkaline Phosphatase / Q000302:isolation & purification / Q000378:metabolism*; D015152:Blotting, Northern; D006457:Hemoglobinuria, Paroxysmal / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000201:enzymology* / Q000235:genetics; D009504:Neutrophils / Q000201:enzymology*; D012333:RNA, Messenger / Q000302:isolation & purification / Q000378:metabolism*; D014158:Transcription, Genetic
D012333:RNA, Messenger; D000469:Alkaline Phosphatase